Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, September 1999, p. 2320-2322, Vol. 43, No. 9
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Activities of New Antimicrobial Agents (Trovafloxacin,
Moxifloxacin, Sanfetrinem, and Quinupristin-Dalfopristin) against
Bacteroides fragilis Group: Comparison with the Activities
of 14 Other Agents
Carmen
Betriu,*
María
Gómez,
M. Luisa
Palau,
Ana
Sánchez, and
Juan J.
Picazo
Servicio de Microbiología
Clínica, Hospital Clínico San Carlos, 28040 Madrid,
Spain
Received 11 March 1999/Returned for modification 13 May
1999/Accepted 29 June 1999
The antimicrobial activities of trovafloxacin, moxifloxacin,
sanfetrinem, quinupristin-dalfopristin, and 14 other antimicrobial agents against 218 Bacteroides fragilis group strains were
determined. A group of 10 imipenem-resistant strains were also tested.
Imipenem, meropenem, and sanfetrinem had the lowest MICs of all of the
-lactams. Quinupristin-dalfopristin inhibited all of the strains at
2 µg/ml. Overall, the MICs of trovafloxacin and moxifloxacin for 90%
of the strains tested were 1 and 2 µg/ml, respectively.
*
Corresponding author. Mailing address: Servicio de
Microbiología Clínica, Hospital Clínico San
Carlos, Plaza Cristo Rey s/n, 28040 Madrid, Spain. Phone: 341 3303486. Fax: 341 3303478. E-mail: cbetriu{at}efd.net.
Antimicrobial Agents and Chemotherapy, September 1999, p. 2320-2322, Vol. 43, No. 9
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Liebetrau, A., Rodloff, A. C., Behra-Miellet, J., Dubreuil, L.
(2003). In Vitro Activities of a New Des-Fluoro(6) Quinolone, Garenoxacin, against Clinical Anaerobic Bacteria. Antimicrob. Agents Chemother.
47: 3667-3671
[Abstract]
[Full Text]
-
Golan, Y., McDermott, L. A., Jacobus, N. V., Goldstein, E. J. C., Finegold, S., Harrell, L. J., Hecht, D. W., Jenkins, S. G., Pierson, C., Venezia, R., Rihs, J., Iannini, P., Gorbach, S. L., Snydman, D. R.
(2003). Emergence of fluoroquinolone resistance among Bacteroides species. J Antimicrob Chemother
52: 208-213
[Abstract]
[Full Text]
-
Hecht, D. W., Osmolski, J. R.
(2003). Activities of Garenoxacin (BMS-284756) and Other Agents against Anaerobic Clinical Isolates. Antimicrob. Agents Chemother.
47: 910-916
[Abstract]
[Full Text]
-
Oteo-Iglesias, J., Alos, J.-I., Gomez-Garces, J.-L.
(2002). Increase in resistance to new fluoroquinolones from 1998 to 2001 in the Bacteroides fragilis group. J Antimicrob Chemother
50: 1055-1057
[Abstract]
[Full Text]
-
Snydman, D. R., Jacobus, N. V., McDermott, L. A., Ruthazer, R., Goldstein, E., Finegold, S., Harrell, L., Hecht, D. W., Jenkins, S., Pierson, C., Venezia, R., Rihs, J., Gorbach, S. L.
(2002). In Vitro Activities of Newer Quinolones against Bacteroides Group Organisms. Antimicrob. Agents Chemother.
46: 3276-3279
[Abstract]
[Full Text]
-
Teng, L.-J., Hsueh, P.-R., Tsai, J.-C., Liaw, S.-J., Ho, S.-W., Luh, K.-T.
(2002). High Incidence of Cefoxitin and Clindamycin Resistance among Anaerobes in Taiwan. Antimicrob. Agents Chemother.
46: 2908-2913
[Abstract]
[Full Text]
-
Betriu, C., Sanchez, A., Palau, M. L., Gomez, M., Picazo, J. J.
(2001). In Vitro Activities of MK-0826 and 16 Other Antimicrobials against Bacteroides fragilis Group Strains. Antimicrob. Agents Chemother.
45: 2372-2374
[Abstract]
[Full Text]
-
Aldridge, K. E., Ashcraft, D., Cambre, K., Pierson, C. L., Jenkins, S. G., Rosenblatt, J. E.
(2001). Multicenter Survey of the Changing In Vitro Antimicrobial Susceptibilities of Clinical Isolates of Bacteroides fragilis Group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus Species. Antimicrob. Agents Chemother.
45: 1238-1243
[Abstract]
[Full Text]